2月18日，现代中药集团(01643)盘中下跌7.32%，截至15:40，报0.38元/股，成交154.12万元。
现代中药集团有限公司专注于补气补血类、心脑血管类、消化系统类、妇科类中成药、新冠病毒及╱或相似病症(自2020财年开始)的创新发展，拥有71个药品批准文号，生产59种中成药产品，其中45种产品被列入《国家医保药品目录》。公司的主要产品，包括补肾填精丸和山玫胶囊等，占据了市场的领先地位，并通过与黑龙江中医药大学和承德医学院的合作，致力于新药品的研发和知识强化。
截至2024年中报，现代中药集团营业总收入7662.4万元、净利润-685.2万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.